|
End-of-day quote
Berne S.E.
10/02/2026
|
5-day change | 1st Jan Change | ||
| 115.86 CHF | +69.18% |
|
+57.76% | +69.18% |
| 06:11pm | HSBC Adjusts Price Target on Gilead Sciences to $175 From $155, Keeps Buy Rating | MT |
| 09-10 | Gilead Sciences, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 11:00 AM |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Gilead Sciences, Inc.(GILD)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Gilead Sciences, Inc.(GILD)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Gilead Sciences, Inc.(GILD)
EBIT
Dividend / Share (DPS)
Data source:
Gilead Sciences, Inc.(GILD)
Cash or Net Debt
- Stock Market
- Stocks
- GILD Stock
- 000935700 Stock
- Consensus Gilead Sciences, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
